CJC-1295 | 4mg

$66.00

Description
Reviews (0)

BUY CJC-1295 | 4mg

In 2026, CJC-1295 (specifically the 4mg vial) is a synthetic analog of Growth Hormone-Releasing Hormone (GHRH) used primarily in clinical research to increase plasma growth hormone (GH) and IGF-1 levels. It is highly valued for its ability to provide a sustained release of GH without the “spike and crash” associated with shorter-acting peptides. [1]

Types and Technical Differences

There are two primary versions often discussed in research:

CJC-1295 with DAC (Drug Affinity Complex): This version includes a “DAC” moiety that allows the peptide to bind to albumin in the bloodstream. This extends its half-life significantly (up to 6–8 days), meaning it only requires 1–2 injections per week. [2]
CJC-1295 No DAC (Modified GRF 1-29): This version has a much shorter half-life (approximately 30 minutes) and is typically administered 1–3 times daily to mimic natural pulsatile GH release. [3]

Core Benefits and Research Uses

Enhanced GH Secretion: It stimulates the anterior pituitary to produce and release more growth hormone naturally. [1]
Body Composition: Research indicates it aids in increasing lean muscle mass, improving protein synthesis, and facilitating lipolysis (fat loss), particularly visceral fat CJC-1295 | 4mg . [4]
Recovery and Repair: It is studied for its ability to accelerate the healing of connective tissues (tendons and ligaments) and improve bone mineral density. [5]
Sleep Quality: 2026 clinical observations continue to support its role in improving deep-wave (REM) sleep, which is critical for physical recovery. [1]

Administration and Protocol

Format: Supplied as a 4mg lyophilized powder that must be reconstituted with Bacteriostatic Water CJC-1295 | 4mg CJC-1295 | 4mg . [3]
Storage: Once reconstituted, the vial must be kept refrigerated at 2°C–8°C to prevent degradation. [2]
Synergy: It is frequently stacked with GHRPs (like GHRP-6 or Ipamorelin) to maximize the “pulse” of growth hormone through a synergistic effect on the pituitary. [1]
Safety and Regulatory Status (2026)
- Side Effects: The most common research-reported side effects include injection site redness, head rush/flushing, and mild water retention. [4]
- Legal Status: Like most peptides, CJC-1295 is designated for “Research Use Only” and is not FDA-approved for general human use. [5]
- Anti-Doping: It is strictly prohibited by the World Anti-Doping Agency (WADA) for use in competitive sports. [6]